These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1855480)
1. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Ferrara N; Clapp C; Weiner R Endocrinology; 1991 Aug; 129(2):896-900. PubMed ID: 1855480 [TBL] [Abstract][Full Text] [Related]
2. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950 [TBL] [Abstract][Full Text] [Related]
3. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Clapp C; Weiner RI Endocrinology; 1992 Mar; 130(3):1380-6. PubMed ID: 1311239 [TBL] [Abstract][Full Text] [Related]
4. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Gonzalez C; Corbacho AM; Eiserich JP; Garcia C; Lopez-Barrera F; Morales-Tlalpan V; Barajas-Espinosa A; Diaz-Muñoz M; Rubio R; Lin SH; Martinez de la Escalera G; Clapp C Endocrinology; 2004 Dec; 145(12):5714-22. PubMed ID: 15358675 [TBL] [Abstract][Full Text] [Related]
5. Proteolysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic, C-terminal 16K fragment by thrombin. Khurana S; Liby K; Buckley AR; Ben-Jonathan N Endocrinology; 1999 Sep; 140(9):4127-32. PubMed ID: 10465285 [TBL] [Abstract][Full Text] [Related]
6. Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance. Piwnica D; Touraine P; Struman I; Tabruyn S; Bolbach G; Clapp C; Martial JA; Kelly PA; Goffin V Mol Endocrinol; 2004 Oct; 18(10):2522-42. PubMed ID: 15192082 [TBL] [Abstract][Full Text] [Related]
7. The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin. Clapp C; Torner L; Gutiérrez-Ospina G; Alcántara E; López-Gómez FJ; Nagano M; Kelly PA; Mejía S; Morales MA; Martínez de la Escalera G Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10384-8. PubMed ID: 7937959 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression. Lee H; Struman I; Clapp C; Martial J; Weiner RI Endocrinology; 1998 Sep; 139(9):3696-703. PubMed ID: 9724020 [TBL] [Abstract][Full Text] [Related]
9. The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation. Martini JF; Piot C; Humeau LM; Struman I; Martial JA; Weiner RI Mol Endocrinol; 2000 Oct; 14(10):1536-49. PubMed ID: 11043570 [TBL] [Abstract][Full Text] [Related]
10. Biological and immunological characterization of cleaved and 16K forms of rat prolactin. Clapp C; Sears PS; Russell DH; Richards J; Levay-Young BK; Nicoll CS Endocrinology; 1988 Jun; 122(6):2892-8. PubMed ID: 3371265 [TBL] [Abstract][Full Text] [Related]
11. Binding studies with intact rat prolactin and a 16K fragment of the hormone. Clapp C; Sears PS; Nicoll CS Endocrinology; 1989 Aug; 125(2):1054-9. PubMed ID: 2752964 [TBL] [Abstract][Full Text] [Related]
12. 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. D'Angelo G; Martini JF; Iiri T; Fantl WJ; Martial J; Weiner RI Mol Endocrinol; 1999 May; 13(5):692-704. PubMed ID: 10319320 [TBL] [Abstract][Full Text] [Related]
13. 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway. Lee SH; Kunz J; Lin SH; Yu-Lee LY Cancer Res; 2007 Nov; 67(22):11045-53. PubMed ID: 18006851 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin. Macotela Y; Aguilar MB; Guzmán-Morales J; Rivera JC; Zermeño C; López-Barrera F; Nava G; Lavalle C; Martínez de la Escalera G; Clapp C J Cell Sci; 2006 May; 119(Pt 9):1790-800. PubMed ID: 16608881 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Dueñas Z; Torner L; Corbacho AM; Ochoa A; Gutiérrez-Ospina G; López-Barrera F; Barrios FA; Berger P; Martínez de la Escalera G; Clapp C Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2498-505. PubMed ID: 10509642 [TBL] [Abstract][Full Text] [Related]
16. The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation. Tabruyn SP; Sabatel C; Nguyen NQ; Verhaeghe C; Castermans K; Malvaux L; Griffioen AW; Martial JA; Struman I Mol Endocrinol; 2007 Jun; 21(6):1422-9. PubMed ID: 17405903 [TBL] [Abstract][Full Text] [Related]
17. Effect of fibroblast growth factor and lipoproteins on the proliferation of endothelial cells derived from bovine adrenal cortex, brain cortex, and corpus luteum capillaries. Gospodarowicz D; Massoglia S; Cheng J; Fujii DK J Cell Physiol; 1986 Apr; 127(1):121-36. PubMed ID: 3958059 [TBL] [Abstract][Full Text] [Related]
18. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2. Hagedorn M; Zilberberg L; Lozano RM; Cuevas P; Canron X; Redondo-Horcajo M; Gimenez-Gallego G; Bikfalvi A FASEB J; 2001 Mar; 15(3):550-2. PubMed ID: 11259363 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms. Clapp C Endocrinology; 1987 Dec; 121(6):2055-64. PubMed ID: 3315634 [TBL] [Abstract][Full Text] [Related]
20. Expression of fibroblast growth factor-5 by bovine choroidal endothelial cells in vitro. Keithahn MA; Aotaki-Keen AE; Schneeberger SA; Hjelmeland LM; Morse LS Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2073-80. PubMed ID: 9331271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]